These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 6290028)
1. Activation of Epstein-Barr virus expression in human lymphoblastoid P3HR-1 and Raji cells with propionic acid and with culture fluids of propionic acid-producing anaerobes. Kishishita M; Yanase S; Ito Y Cancer Lett; 1982; 16(2):117-20. PubMed ID: 6290028 [TBL] [Abstract][Full Text] [Related]
2. Effect of short-chain fatty acids on Epstein-Barr virus early and viral capsid antigen induction in P3HR-1 cells. Kawanishi M; Ito Y Cancer Lett; 1980 Dec; 11(2):129-32. PubMed ID: 6257378 [TBL] [Abstract][Full Text] [Related]
3. Effects of n-butyrate on Epstein-Barr virus-carrying lymphoma lines. Anisimová E; Saemundsen AK; Roubal J; Vonka V; Klein G J Gen Virol; 1982 Jan; 58 Pt 1():163-71. PubMed ID: 6292341 [TBL] [Abstract][Full Text] [Related]
4. Relationship between Epstein-Barr virus genome number, amount of nuclear antigen, and early antigen inducibility in diploid and tetraploid lymphoma cells of related origin. Shapiro IM; Luka J; Andersson-Anvret M; Klein G Intervirology; 1979; 12(1):19-25. PubMed ID: 227812 [TBL] [Abstract][Full Text] [Related]
5. Combined effect of the extracts from Croton tiglium, Euphorbia lathyris or Euphorbia tirucalli and n-butyrate on Epstein-Barr virus expression in human lymphoblastoid P3HR-1 and Raji cells. Ito Y; Kawanishi M; Harayama T; Takabayashi S Cancer Lett; 1981 Apr; 12(3):175-80. PubMed ID: 6266651 [TBL] [Abstract][Full Text] [Related]
6. High Epstein-Barr virus (EBV) susceptibility of both lymphoblastoid and lymphoma cell lines derived from a Japanese patient with EBV genome-positive Burkitt's lymphoma. Okano M; Aya T; Mizuno F; Takada K; Osato T Tohoku J Exp Med; 1993 Jun; 170(2):71-9. PubMed ID: 8266328 [TBL] [Abstract][Full Text] [Related]
7. Productive Epstein-Barr viral infection of the human lymphoblastoid cell line 6410 with release of early antigen inducing and transforming virus. Traul KA; Stephens R; Gerber P; Peterson WD Int J Cancer; 1977 Aug; 20(2):247-55. PubMed ID: 197026 [TBL] [Abstract][Full Text] [Related]
8. Primary EBV infection of human umbilical cord lymphocytes and EBV genome-negative lymphoblastoid cell lines (BJAB and Ramos). Takimoto T; Sato H; Ogura H Auris Nasus Larynx; 1986; 13(3):199-205. PubMed ID: 3036055 [TBL] [Abstract][Full Text] [Related]
9. [Suppressive effect of CDDP on induction of the Epstein-Barr virus antigen synthesis by n-butyrate]. Furukawa M; Kato C; Kamide M; Umeda R Nihon Jibiinkoka Gakkai Kaiho; 1989 Feb; 92(2):189-93. PubMed ID: 2545850 [TBL] [Abstract][Full Text] [Related]
10. Analysis of epstein-Barr virus (EBV) of P3HR-1: isolation of EBV with EBNA induction ability in human cord lymphocytes and without EA induction ability in Raji cells. Yano S; Tanaka A; Takada K; Fujiwara S; Osato T; Nonoyama M Virology; 1982 Jun; 119(2):392-8. PubMed ID: 6281981 [No Abstract] [Full Text] [Related]
11. Recovery of transforming EBV from non-producer cells after superinfection with non-transforming P3HR-1 EBV. Fresen KO; Cho MS; zur Hausen H Int J Cancer; 1978 Oct; 22(4):378-83. PubMed ID: 212377 [TBL] [Abstract][Full Text] [Related]
12. Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. II. Epstein-Barr virus induction patterns. Klein G; Zeuthen J; Ber R; Ernberg I J Natl Cancer Inst; 1982 Feb; 68(2):197-202. PubMed ID: 6278188 [TBL] [Abstract][Full Text] [Related]
13. Relationship between Epstein-Barr virus nuclear antigen and DNA genome number in superinfected and induced lymphoblastoid cell lines. Boguszaková L; Hirsch I; Brichácek B; Vonka V J Gen Virol; 1983 Apr; 64 (Pt 4)():887-94. PubMed ID: 6300308 [TBL] [Abstract][Full Text] [Related]
14. Transient induction of a nuclear antigen unrelated to Epstein-Barr nuclear antigen in cells of two human B-lymphoma lines converted by Epstein-Barr virus. Fresen KO; zur Hausen H Proc Natl Acad Sci U S A; 1977 Jan; 74(1):363-6. PubMed ID: 189313 [TBL] [Abstract][Full Text] [Related]
15. Effect of adenine arabinoside on Epstein-Barr virus in vitro. Coker-Vann M; Dolin R J Infect Dis; 1977 Mar; 135(3):447-53. PubMed ID: 191542 [TBL] [Abstract][Full Text] [Related]
17. An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection. Klein G; Giovanella B; Westman A; Stehlin JS; Mumford D Intervirology; 1975; 5(6):319-34. PubMed ID: 181343 [TBL] [Abstract][Full Text] [Related]
18. Suppression of Epstein-Barr virus reactivation in lymphoblastoid cells cultured in simulated microgravity. Long JP; Pierson S; Hughes JH In Vitro Cell Dev Biol Anim; 1999 Jan; 35(1):49-54. PubMed ID: 10475255 [TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus carried by Raji cells: a mutant in early functions? Kallin B; Klein G Intervirology; 1983; 19(1):47-51. PubMed ID: 6298144 [TBL] [Abstract][Full Text] [Related]
20. Persistence of a repressed Epstein-Barr virus genome in Burkitt lymphoma cells made resistant to 5-bromodeoxyuridine. Hampar B; Derge JG; Martos LM; Walker JL Proc Natl Acad Sci U S A; 1971 Dec; 68(12):3185-9. PubMed ID: 4332012 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]